We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

RNasin® Ribonuclease Inhibitors: Superior Performance for All of Your RNA Analysis Needs

  • Print
  • Email

Abstract

Over 6,000 papers have cited RNasin® Ribonuclease Inhibitors as the source of RNase protection since Promega introduced RNasin® Inhibitors in 1982, making them the most trusted reagents for RNA protection. RNasin® Inhibitors work by binding strongly to RNases, preventing them from degrading vulnerable RNA molecules during manipulation in the laboratory. RNase inhibitors work in a variety of experimental situations and conditions. Reliable RNase inhibitors satisfy three major criteria. This article presents these criteria and shows that RNasin® Ribonuclease Inhibitors fulfill them, ensuring that RNases will not interfere with your RNA analysis work.

Promega Notes 86, 25–27.

Kyle Hooper

Promega Corporation
Publication Date: 2004

Download Article (163 KB)

Choose your country

Americas

Brazil
Canada
United States

Pacific Asia

Australia
India
Japan
Korea, Republic of
Singapore

Europe

Austria
Belgium
Denmark
Estonia
Finland
France
Germany
Iceland
Italy
Luxembourg
Netherlands
Norway
Poland
Spain
Sweden
Switzerland
United Kingdom